Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
NewAmsterdam Pharma Community
NasdaqGM:NAMS Community
0
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
NewAmsterdam Pharma
Popular
Undervalued
Overvalued
Community Investing Ideas
There are no community narratives available.
Your Valuation for
NAMS
NAMS
NewAmsterdam Pharma
Your Fair Value
US$
Current Price
US$23.98
90.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-264m
433m
2015
2018
2021
2024
2025
2027
2030
Revenue US$432.9m
Earnings US$87.8m
Advanced
Set Fair Value
